Fetuin-A in Activated Liver Macrophages Is a Key Feature of Non-Alcoholic Steatohepatitis.
adipose tissue
diabetes
fetuin-A
foz mice
humans
insulin resistance
liver
metabolic dysfunction-associated fatty liver disease
non-alcoholic steatohepatitis
Journal
Metabolites
ISSN: 2218-1989
Titre abrégé: Metabolites
Pays: Switzerland
ID NLM: 101578790
Informations de publication
Date de publication:
07 Jul 2022
07 Jul 2022
Historique:
received:
27
05
2022
revised:
28
06
2022
accepted:
04
07
2022
entrez:
27
7
2022
pubmed:
28
7
2022
medline:
28
7
2022
Statut:
epublish
Résumé
Fetuin-A, a plasma multifunctional protein known to play a role in insulin resistance, is usually presented as a liver secreted protein. However, fetuin-A adipose tissue production has been also described. Here, we evaluated fetuin-A production by the liver and the adipose tissue during metabolic dysfunction-associated fatty liver disease (MAFLD)-non-alcoholic steatohepatitis (NASH) development. Fetuin-A was evaluated by enzyme-linked immunosorbent assay (ELISA), polymerase chain reaction (PCR), Western blot, and immunofluorescence in male foz
Identifiants
pubmed: 35888749
pii: metabo12070625
doi: 10.3390/metabo12070625
pmc: PMC9319870
pii:
doi:
Types de publication
Journal Article
Langues
eng
Subventions
Organisme : Fund for Scientific Research
ID : Fonds de la Recherche Scientifique
Références
Clin Sci (Lond). 2017 Feb 1;131(4):285-296
pubmed: 27803297
Atherosclerosis. 2015 Jul;241(1):130-7
pubmed: 25978344
Biochem Biophys Res Commun. 2006 Jul 14;345(4):1414-24
pubmed: 16729974
JHEP Rep. 2019 Feb 23;1(1):30-43
pubmed: 32149275
Acta Gastroenterol Belg. 2018 Jan-Mar;81(1):55-81
pubmed: 29562379
Nat Med. 2012 Aug;18(8):1279-85
pubmed: 22842477
N Engl J Med. ;377(15):1495
pubmed: 29022333
Biochem J. 2010 Aug 1;429(3):451-62
pubmed: 20482516
JHEP Rep. 2019 Aug 30;1(4):329-341
pubmed: 32039383
Acta Gastroenterol Belg. 2020 Oct-Dec;83(4):513-515
pubmed: 33321005
PLoS One. 2018 Feb 9;13(2):e0192663
pubmed: 29425212
Diabetes. 2013 Jan;62(1):49-55
pubmed: 22923470
Nature. 2022 Mar;603(7902):736-742
pubmed: 35264794
Cell Signal. 2013 Apr;25(4):981-8
pubmed: 23314177
J Biol Chem. 2004 Jul 30;279(31):32345-53
pubmed: 15166226
Diabetes Care. 2006 Apr;29(4):853-7
pubmed: 16567827
Acta Gastroenterol Belg. 2022 Apr-Jun;85(2):346-357
pubmed: 35709779
J Biol Chem. 2013 Sep 27;288(39):28324-30
pubmed: 23943623
J Nutr Biochem. 2011 Jan;22(1):38-45
pubmed: 20303728
J Gastroenterol Hepatol. 2018 Jul;33(7):1312-1320
pubmed: 29424123
J Clin Invest. 2007 Jan;117(1):175-84
pubmed: 17200717
JAMA. 2020 Mar 24;323(12):1175-1183
pubmed: 32207804
Am J Physiol Endocrinol Metab. 2018 Mar 1;314(3):E266-E273
pubmed: 29138227
Adv Clin Chem. 2019;89:79-130
pubmed: 30797472
Lipids Health Dis. 2018 Dec 22;17(1):291
pubmed: 30579336
Endocrine. 2017 Feb;55(2):435-446
pubmed: 27738888
FASEB J. 2011 Dec;25(12):4301-11
pubmed: 21873555
PLoS One. 2016 Jul 25;11(7):e0159524
pubmed: 27454866
J Clin Transl Hepatol. 2021 Feb 28;9(1):3-14
pubmed: 33604250
Hepatology. 2014 Apr;59(4):1393-405
pubmed: 24254368
Diabetes. 2007 Jan;56(1):16-23
pubmed: 17192460
Mol Endocrinol. 1993 Nov;7(11):1445-55
pubmed: 7906861
Diabetes. 2002 Aug;51(8):2450-8
pubmed: 12145157
Nat Rev Gastroenterol Hepatol. 2019 Mar;16(3):145-159
pubmed: 30482910
Liver Int. 2014 Aug;34(7):1084-93
pubmed: 24107103
J Clin Invest. 2006 Jun;116(6):1494-505
pubmed: 16691291
Best Pract Res Clin Gastroenterol. 2014 Aug;28(4):545-58
pubmed: 25194174
J Endocrinol Invest. 2021 Jan;44(1):105-110
pubmed: 32350824
World J Hepatol. 2015 Sep 8;7(19):2184-8
pubmed: 26380042
Biochem Biophys Res Commun. 2006 Apr 21;342(4):1152-9
pubmed: 16516152
Nat Rev Endocrinol. 2017 Sep;13(9):509-520
pubmed: 28621339
Metabolites. 2022 Mar 29;12(4):
pubmed: 35448487
Am J Physiol Gastrointest Liver Physiol. 2010 Jan;298(1):G107-16
pubmed: 19875703
J Physiol. 2009 May 15;587(Pt 10):2387-97
pubmed: 19332493
Am J Physiol Gastrointest Liver Physiol. 2012 Jun 1;302(11):G1310-21
pubmed: 22442158
J Clin Invest. 2003 Dec;112(12):1796-808
pubmed: 14679176